Treatment of severe pertussis: a study of the safety and pharmacology of intravenous pertussis immunoglobulin.

Bruss, J B; Malley, R; Halperin, S; Dobson, S; Dhalla, M; Mciver, J; Siber, G R

Bruss, J B; Malley, R; Halperin, S; Dobson, S; Dhalla, M; Mciver, J; Siber, G R.

Affiliation

Bruss JB; Children's Hospital, Harvard Medical School, Dana Farber Cancer Institute, Boston, MA, USA. JBBRUSS@am.pnu.com

Pediatr Infect Dis J ; 18(6): 505-11, 1999 Jun.

Article in En | MEDLINE | ID: mdl-10391179

Subject(s)

Antibodies, Bacterial/immunology; Bordetella pertussis/immunology; Immunoglobulins, Intravenous/therapeutic use; Pertussis Toxin; Virulence Factors, Bordetella/immunology; Whooping Cough/drug therapy; Humans; Immunoglobulins, Intravenous/immunology; Immunoglobulins, Intravenous/pharmacokinetics; Infant; Whooping Cough/immunology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bordetella pertussis / Virulence Factors, Bordetella / Whooping Cough / Immunoglobulins, Intravenous / Pertussis Toxin / Antibodies, Bacterial Type of study: Clinical_trials Limits: Humans / Infant Language: En Journal: Pediatr Infect Dis J Journal subject: DOENCAS TRANSMISSIVEIS / PEDIATRIA Year: 1999 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links